Your browser doesn't support javascript.
loading
Genetic and phenotypic stability of poliovirus shed from infants who received novel type 2 or Sabin type 2 oral poliovirus vaccines in Panama: an analysis of two clinical trials.
Wahid, Rahnuma; Mercer, Laina D; De Leon, Tirza; DeAntonio, Rodrigo; Sáez-Llorens, Xavier; Macadam, Andrew; Chumakov, Konstantin; Strating, Jeroen; Koel, Björn; Konopka-Anstadt, Jennifer L; Oberste, M Steven; Burns, Cara C; Andino, Raul; Tritama, Erman; Bandyopadhyay, Ananda S; Aguirre, Gabriela; Rüttimann, Ricardo; Gast, Chris; Konz, John O.
Afiliación
  • Wahid R; Center for Vaccine Innovation and Access, PATH, Seattle, WA, USA.
  • Mercer LD; Center for Vaccine Innovation and Access, PATH, Seattle, WA, USA.
  • De Leon T; Hospital Materno Infantil José Domingo De Obaldía, David, Panama; CEVAXIN, Centro de Vacunación e Investigación, Panama City, Panama.
  • DeAntonio R; CEVAXIN, Centro de Vacunación e Investigación, Panama City, Panama.
  • Sáez-Llorens X; CEVAXIN, Centro de Vacunación e Investigación, Panama City, Panama; Department of Infectious Diseases, Hospital del Niño Dr José Renán Esquivel and Sistema Nacional de Investigación at Secretaria Nacional de Ciencia y Tecnologia, Panama City, Panama.
  • Macadam A; Division of Virology, National Institute for Biological Standards and Control, South Mimms, UK.
  • Chumakov K; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA; Global Virus Network Center of Excellence, Baltimore, MD, USA.
  • Strating J; Viroclinics Biosciences, Rotterdam, Netherlands.
  • Koel B; Viroclinics Xplore, Viroclinics Biosciences, Rotterdam, Netherlands.
  • Konopka-Anstadt JL; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Oberste MS; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Burns CC; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Andino R; Department of Microbiology and Immunology, University of California, San Francisco, CA, USA.
  • Tritama E; Research and Development Division, PT Bio Farma, Bandung, West Java, Indonesia.
  • Bandyopadhyay AS; Bill & Melinda Gates Foundation, Seattle, WA, USA.
  • Aguirre G; Fighting Infectious Diseases in Emerging Countries, Miami, FL, USA.
  • Rüttimann R; Fighting Infectious Diseases in Emerging Countries, Miami, FL, USA.
  • Gast C; Center for Vaccine Innovation and Access, PATH, Seattle, WA, USA.
  • Konz JO; Center for Vaccine Innovation and Access, PATH, Seattle, WA, USA. Electronic address: jkonz@path.org.
Lancet Microbe ; 3(12): e912-e921, 2022 12.
Article en En | MEDLINE | ID: mdl-36332645
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Poliomielitis / Poliovirus Tipo de estudio: Prognostic_studies Límite: Animals País/Región como asunto: America central / Panama Idioma: En Revista: Lancet Microbe Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Poliomielitis / Poliovirus Tipo de estudio: Prognostic_studies Límite: Animals País/Región como asunto: America central / Panama Idioma: En Revista: Lancet Microbe Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos